WASHINGTON, July 22 -- The Association for Accessible Medicines issued the following news release on July 20, 2026:

* * *

Biosimilars Council and AAM Lauds House Markup of Expedited Access to Biosimilars Act and Biosimilars Red Tape Elimination Act

Legislative progress codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies; Eliminates arbitrary distinction between interchangeable biologics and biosimilars